Article ID Journal Published Year Pages File Type
6242533 Respiratory Medicine 2011 13 Pages PDF
Abstract
Most patients with moderate to very severe COPD exhibit ATS-defined bronchodilator reversibility based on flow and lung volume measures after budesonide/formoterol pMDI or formoterol treatment. Budesonide/formoterol pMDI also has a rapid (within 5 min) onset of bronchodilation that is maintained over time compared with formoterol alone.
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
, , , , ,